| Title |
Risk of renal impairment after treatment with ibandronate versus zoledronic acid: a retrospective medical records review
|
|---|---|
| Published in |
Supportive Care in Cancer, December 2008
|
| DOI | 10.1007/s00520-008-0553-7 |
| Pubmed ID | |
| Authors |
Ingo J. Diel, Rudolf Weide, Hubert Köppler, Lucia Antràs, Michael Smith, Jesse Green, Neil Wintfeld, Maureen Neary, Mei Sheng Duh |
| Abstract |
This retrospective study compared renal impairment rates in breast cancer, multiple myeloma, prostate cancer and non-small cell lung cancer patients treated with ibandronate or zoledronic acid. |
Mendeley readers
The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Italy | 1 | 3% |
| Unknown | 35 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 10 | 28% |
| Other | 6 | 17% |
| Student > Ph. D. Student | 4 | 11% |
| Student > Master | 3 | 8% |
| Student > Doctoral Student | 2 | 6% |
| Other | 5 | 14% |
| Unknown | 6 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 22 | 61% |
| Social Sciences | 2 | 6% |
| Computer Science | 1 | 3% |
| Biochemistry, Genetics and Molecular Biology | 1 | 3% |
| Nursing and Health Professions | 1 | 3% |
| Other | 1 | 3% |
| Unknown | 8 | 22% |